drugset / Trial / NCT05556265
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of deucravacitinib versus placebo at Week 24 and safety and tolerability of deucravacitinib versus placebo in adults with alopecia areata.
Timeline
- Start
- 2022-11-08
- Primary completion
- 2024-01-06
- Completion
- 2024-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | — |